Compare IVR & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVR | NAGE |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.3M | 507.6M |
| IPO Year | N/A | N/A |
| Metric | IVR | NAGE |
|---|---|---|
| Price | $8.51 | $5.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.25 | ★ $16.33 |
| AVG Volume (30 Days) | ★ 2.5M | 802.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 17.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $150.63 | $30.37 |
| Revenue Next Year | N/A | $20.36 |
| P/E Ratio | ★ $6.63 | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.86 | $4.74 |
| 52 Week High | $9.50 | $14.66 |
| Indicator | IVR | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 43.11 | 41.96 |
| Support Level | $7.16 | N/A |
| Resistance Level | $9.10 | $5.32 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 31.96 | 68.37 |
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.